Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone plus misoprostol versus misoprostol alone for medical management of missed miscarriage
ISRCTN17405024Phase 3Completed
- Sponsor
- University of Birmingham
- Start
- Sep 2017
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in Pregnancy loss comparing Mifepristone plus misoprostol with Placebo plus misoprostol (2 arms). Primary endpoint: Failure to spontaneously pass the gestational sac within 7 days after randomisation. Started Sep 2017; status: completed.
02
Drugs
mifepristonemisoprostol
03
Conditions
Pregnancy loss
Beyond the preview
Go deeper on ISRCTN17405024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN17405024.